Global Urology Catheters Market Size By Type (Intermittent Catheters, Foley/Indwelling Catheters), By Application (Hospitals, Clinics), By Region, And Segment Forecasts, 2023 to 2032

The Global Urology Catheters Market was valued at USD 2.9 billion in 2023 and is projected to surpass USD 5.1 billion by 2031, growing at a CAGR of 7.3% during the forecast period from 2023 to 2031. The rising prevalence of urological disorders such as urinary incontinence, benign prostatic hyperplasia (BPH), and bladder dysfunction, alongside increasing geriatric populations, is significantly boosting market growth. Furthermore, technological advancements in catheter design, such as antimicrobial coatings and hydrophilic properties, are enhancing patient comfort and reducing infection risks, driving further adoption in both hospitals and home care settings.

Drivers:

1. Increasing Prevalence of Urological Disorders:

Conditions such as urinary retention, prostate enlargement, and incontinence are becoming more common, especially among the elderly, necessitating the regular use of urology catheters for treatment and management.

2. Aging Global Population:

With people aged 65 and over constituting a growing share of the population, age-associated urological issues are increasing, fueling the demand for long-term catheterization and intermittent catheters.

3. Rising Hospitalization Rates and Surgical Procedures:

The increasing number of surgeries—particularly urological, gynecological, and post-operative procedures—boosts the need for indwelling catheters to manage urinary drainage during recovery.

Restraints:

1. Risk of Catheter-Associated Urinary Tract Infections (CAUTIs):

Despite technological progress, catheters continue to carry a risk of infection, leading to complications that may hinder patient trust and regulatory approvals.

2. Stringent Regulatory Frameworks:

Obtaining regulatory approvals for new urology catheters involves extensive testing and documentation, which can delay product launches and increase costs for manufacturers.

Opportunity:

1. Technological Innovations in Catheter Design:

Development of antimicrobial, hydrophilic, and user-friendly catheter products offers lucrative opportunities for companies aiming to improve patient safety and convenience.

2. Growth in Home Healthcare Sector:

As more patients prefer treatment at home, especially post-COVID, there is a rising demand for self-catheterization devices, particularly intermittent catheters with ease-of-use features.

3. Emerging Markets in Asia-Pacific and Latin America:

Rapid healthcare infrastructure development and growing awareness about urological care in emerging regions create favorable conditions for market expansion.

Market by System Type Insights:

Intermittent Catheters emerged as the leading segment in 2023, driven by their cost-effectiveness, lower infection risks, and increasing suitability for self-catheterization. Innovations in compact and pre-lubricated variants have enhanced usability, especially for the aging population and those with spinal cord injuries.

Foley Catheters, although still widely used in hospitals for longer-term applications, are witnessing slower growth due to increasing concerns over CAUTIs and a shift toward less invasive alternatives.

Market by End-use Insights:

Hospitals held the largest market share in 2023, accounting for over 45% of total revenue. The high usage of catheters in inpatient care, surgeries, and emergency interventions ensures sustained demand. However, the homecare segment is growing rapidly, driven by the rising acceptance of intermittent catheters and increasing focus on cost-effective chronic care.

Market by Regional Insights:

North America dominated the market in 2023 due to advanced healthcare infrastructure, high awareness levels, and the presence of key industry players. However, Asia-Pacific is projected to witness the fastest growth during the forecast period, supported by expanding healthcare access, government health programs, and rising incidence of age-related disorders.

Competitive Scenario:

Key players in the Global Urology Catheters Market include Becton, Dickinson and Company (BD), Coloplast, Hollister Incorporated, Teleflex Incorporated, ConvaTec Group PLC, B. Braun Melsungen AG, Cook Medical, Medline Industries, and Wellspect Healthcare. These companies are investing in R&D, product launches, and geographic expansion to gain competitive advantages.

Scope of Work – Global Urology Catheters Market

Key Market Developments:

2023: Coloplast launched a new compact hydrophilic intermittent catheter targeting active users for better portability and discretion.

2024: BD introduced an antimicrobial Foley catheter with extended protection against CAUTIs, aiming to reduce hospital-acquired infections.

2025: Teleflex expanded its catheter production facility in the U.S. to meet increasing demand in North America and export markets.

FAQs:

1) What is the current market size of the Global Urology Catheters Market?

The market was valued at USD 2.9 billion in 2023.

2) What is the major growth driver of the Global Urology Catheters Market?

The major driver is the rising prevalence of urological disorders and the aging population.

3) Which is the largest region during the forecast period in the Global Urology Catheters Market?

North America held the largest market share in 2023, while Asia-Pacific is expected to grow fastest.

4) Which segment accounted for the largest market share in the Global Urology Catheters Market?

The Intermittent Catheters segment accounted for the largest share in 2023.

5) Who are the key market players in the Global Urology Catheters Market?

Major players include BD, Coloplast, Hollister, Teleflex, ConvaTec, B. Braun, and Cook Medical.